scispace - formally typeset
L

Louise Carlson

Researcher at National Institutes of Health

Publications -  18
Citations -  3766

Louise Carlson is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Transcription factor & Internal medicine. The author has an hindex of 13, co-authored 15 publications receiving 3669 citations.

Papers
More filters
Journal ArticleDOI

Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation

TL;DR: Results suggest that phosphorylation at one or both of these residues is critical for activation of NF-kappa B, the transcription factor inhibited by I kappa B-alpha.
Journal ArticleDOI

Requirement for NF-κB in osteoclast and B-cell development

TL;DR: It is demonstrated that unlike the respective single knockout mice, the p50/p52 double knockout mice fail to generate mature osteoclasts and B cells, apparently because of defects that track with these lineages in adoptive transfer experiments.
Journal ArticleDOI

Mice Deficient in Nuclear Factor (NF)-κB/p52 Present with Defects in Humoral Responses, Germinal Center Reactions, and Splenic Microarchitecture

TL;DR: These phenotypes are largely overlapping with those observed in Bcl-3 knockout animals, but distinct from those of p50 knockouts, supporting the notion of a physiologically relevant complex of p52 homodimers and B cl-3.
Journal ArticleDOI

Critical Roles for the Bcl-3 Oncoprotein in T Cell–Mediated Immunity, Splenic Microarchitecture, and Germinal Center Reactions

TL;DR: Critical roles for Bcl-3 in antigen-specific priming of T and B cells are revealed and altered microarchitecture of secondary lymphoid organs in mutant mice, including partial loss of B cells, may underlie the immunologic defects.
Journal ArticleDOI

NF‐κB p50 and p52 Expression Is Not Required for RANK‐Expressing Osteoclast Progenitor Formation but Is Essential for RANK‐ and Cytokine‐Mediated Osteoclastogenesis

TL;DR: NF‐κB p50 and p52 expression is not required for formation of RANK‐expressing osteoclast progenitors but is essential for RANK'S osteocline precursors to differentiate into TRAP+ osteoclasts in response to RANKL and other osteOClastogenic cytokines.